Pestalozzi advises Johnson & Johnson Innovation – JJDC, Inc. in connection with the IPO of Molecular Partners AG
Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. as investor in connection with the pre-IPO corporate restructuring steps and the IPO of Molecular Partners AG, a Schlieren based biotech company (SIX: MOLN), which went public on SIX Swiss Exchange in November 2014.